Resultados de búsqueda - Shazli Azmi

Target Trial Emulations of GLP ‐1 and Dual GLP ‐1/ GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes por Alex E. Henney, David R. Riley, Matthew Anson, Shazli Azmi, Uazman Alam, Daniel J. Cuthbertson

Enlace del recurso

Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab Debate por Gordon Sloan, Shazli Azmi, Stephanie Eid, Maryam Ferdousi, Johan Røikjer, Zoltan Kender, Luca D'Onofrio, Eleni Karlafti, Brian Callaghan, Bruce A. Perkins

Enlace del recurso

The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: A real‐world retrospective cohort study por Sophie Haughton, David Riley, Simon Berry, Muhammad Fahad Arshad, Aikaterini Eleftheriadou, Matthew Anson, Yew Wen Yap, Daniel J. Cuthbertson, Rayaz A. Malik, Shazli Azmi, Uazman Alam, Ahmed Iqbal

Enlace del recurso